menu

Quintiles Library

Show Filters
Case Study
Developing a flexible study approach and recruiting and retaining the right patients.
Read More
Infographic
Vaccines have reduced the morbidity from vaccine-preventable diseases by up to 100% in the 20th century. You need one global partner to support your research from discovery to post-market. Learn how we helped develop or commercialize the top 30 best-selling vaccine products of 2014.
Read More
Infographic
Developing cancer treatments requires the right strategic approach to manage risks and make critical go/no-go decisions. Partner with Quintiles for the global scientific, clinical and technological resources needed for successful oncology drug development.
Read More
Infographic
You know the barriers to CV innovation. Pressures on development costs. Expanding regulatory requirements. Larger, longer and more complex clinical trials. Partner with Quintiles for the global scientific, clinical and technological resources needed for successful cardiovascular drug development.
Read More
Infographic
オンコロジーの臨床開発:インフォグラフィック   クインタイルズの臨床試験、リソースやグローバルなセントラルラボが2013年度の上位45のオンコロジー医薬品の開発・上市に役立っています。詳細はリンク先をご覧ください。コンテンツは日本語です。
Read More
Infographic
With nearly 1% of the world's population affected by rheumatoid arthritis, you need one global partner to support your research from discovery to post-market. Learn about how our clinical resources and global labs have helped us develop or commercialize the top 40 rheumatology drugs of 2013.
Read More
Infographic
The prevalence of diabetes is expected to increase 55% in the next 20 years, rising from 382 million people living with diabetes in 2013 to 592 million by 2035. You need one global partner to support your research from discovery to post-market. Learn how we helped develop or commercialize the top 30 diabetes drugs of 2013.
Read More
Fact Sheet
How can you maximize the value of your real-world evidence activities? Engage a dedicated and specialized global team of highly qualified scientific experts across the globe. Quintiles' Scientific Affairs team is positioned to help you succeed.
Read More
Fact Sheet
Generic drug development comes with its own set of challenges, including timing and pricing pressures, global execution and therapeutic complexity. Quintiles’ new lean delivery model can help you confront these challenges, to rapidly and predictably execute your Phase III therapeutic equivalence studies and first to file opportunities.
Read More
Fact Sheet
We’ve streamlined our proven operating model to the distinct needs of generics sponsors. From bioequivalence studies to more complex therapeutic equivalence trials, we can give you what you’ve been looking for: a dedicated partner to fully manage study design and delivery at competitive pricing. You’ll still be able to harness our industry-leading global site network,...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – December 10, 2015 – Quintiles, the world’s largest provider of biopharmaceutical services, today announced the launch of its Integrated Asset Development Plan (IADP) offering. This new suite of services combines development strategy, regulatory strategy, market and patient access and commercial expertise, with in-depth therapeutic knowledge,...
Read More
Video
An integrated asset development plan is a comprehensive approach to the development of a medicinal or therapeutic asset. This can include small molecules, biologics, medical devices, novel therapeutic agents, or even a combination of any of these. .p3sdk-logo-container { width: 800px; position: absolute; background: #f1f1f1; margin-bottom: 8px; ...
Presentation
Hiren Thakkar, Senior Clinical Project Manager, Real World Late Phase Research, share insights on  considerations  when exploring different methods to maintain appropriate temperature of your product and assured best quality at your facilities.  Topics discussed include: Pinpointing typical issues with temperature excursion at site level in the clinical supply...
Explore More
Infographic
With 22 million new cancer cases projected by 2030, you need one global partner to support your research from discovery to post-market. Click on our infographic to learn about how our clinical resources and global central labs have helped us develop or commercialize the top 45 oncology drugs of 2013.
Read More
Fact Sheet
The Quintiles Clinical Program Design offering, powered by our state-of-the-art technology, Quintiles Infosario® Design, combines extensive industry data, objective experts and a facilitated design process to drive more informed strategic clinical program and trial planning.
Read More
Fact Sheet
Quintiles Live! e-detailing channel is an online meeting platform used by qualified remote eRepresentatives to conduct 1:1 virtual meetings with physicians. Quintiles conducted market research to help evaluate the Live! e-detailing channel. This infographic highlights the impact of remote e-detailing in terms of the value of the call and quality of the experience.
Read More
Fact Sheet
Quintiles Live! e-detailing channel is an online meeting platform used by qualified remote eRepresentatives to conduct 1:1 virtual meetings with physicians. Quintiles conducted market research to help evaluate the Live! e-detailing channel. This infographic highlights the quality of the physicians experience of using remote e-detailing, perceived benefits and its impact...
Read More
Fact Sheet
Quintiles Live! e-detailing channel is an online meeting platform used by qualified remote eRepresentatives to conduct 1:1 virtual meetings with physicians. Quintiles conducted market research to help evaluate the Live! e-detailing channel. This infographic highlights the impact of remote e-detailing in terms of Impact on clinical practice and physicians' prescribing...
Read More
Fact Sheet
Quintiles Live! e-detailing channel is an online meeting platform used by qualified remote eRepresentatives to conduct 1:1 virtual meetings with physicians. Quintiles conducted market research to help evaluate the Live! e-detailing channel. This infographic highlights the impact of remote e-detailing in terms of physicians’ future channel preferences.
Read More
Fact Sheet
When developing a product for the Asian markets, pharmaceutical companies require not only an intimate knowledge of the regulatory landscape and the requirements for Asia, but also a clear understanding of the medical landscape, treatment guidelines, manufacturing considerations among others.
Read More